Cancer Researchers Begin Large Long-Term Study of Black Women
The American Cancer Society hopes to enroll 100,000 women and follow them for three decades to discover what’s causing higher case and death rates.
Supported byCancer Researchers Begin Large Long-Term Study of Black WomenThe American Cancer Society hopes to enroll 100,000 women and follow them for three decades to discover what’s causing higher case and death rates.ByRoni Caryn RabinThe American Cancer Society has begun an ambitious, far-reaching study focusing on a population that has long been overlooked, despite high rates of cancer and cancer-related deaths: Black women.The initiative, called VOICES of Black Women, is believed to be the first long-term population study of its size to zero in specifically on the factors driving cancer prevalence and deaths among Black women.Researchers plan toenroll 100,000 Black womenwithout cancer, ages 25 to 55, in Washington, D.C., and 20 states where most Black American women reside. The subjects will be surveyed twice a year about their behaviors, environmental exposures and life experiences, and followed for 30 years; any cancers they may develop will be tracked.Similar studies by the American Cancer Society in the past yielded critical lessons about what causes cancer — for example, identifying cigarette smoking as a cause of lung cancer and linking red- and processed-meat consumption to increased risk of colon cancer.While some earlier studies have included large numbers of Black women, the research wasn’t able to “hone in on the specific drivers of cancer in that population,” said Dr. Alpa Patel, senior vice president of population science at the society and co-principal investigator of the VOICES study, along with Dr. Lauren McCullough.“In general population studies, you tend to ask questions that are going to be applicable to the majority of the population,” she said. “So going deeply into the lived experiences of discrimination, bias, systematic issues, environmental influences and cultural aspects of health-related behaviors, and how the narratives around them are shaped in different populations — those types of unique aspects of understanding what contributes to cancer in a population weren’t being asked about.”
[{"title": "Cancer Researchers Begin Large Long-Term Study of Black ...", "link": "https://www.nytimes.com/2024/06/07/health/cancer-black-women.html#:~:text=black%2Dwomen.html-,Cancer%20Researchers%20Begin%20Large%20Long%2DTerm%20Study%20of%20Black%20Women,higher%20case%20and%20death%20rates."}, {"title": "Cancer Researchers Begin Large Long-Term Study of Black ...", "link": "https://www.nytimes.com/2024/06/07/health/cancer-black-women.html#:~:text=black%2Dwomen.html-,Cancer%20Researchers%20Begin%20Large%20Long%2DTerm%20Study%20of%20Black%20Women,higher%20case%20and%20death%20rates."}, {"title": "VOICES of Black Women\u00ae study", "link": "https://pressroom.cancer.org/releases?item=1322"}, {"title": "Major study of cancer in Black women launches in 20 states", "link": "https://www.nbcnews.com/health/cancer/cancer-black-women-study-launches-rcna150880"}, {"title": "Largest study of its kind to investigate why Black women ...", "link": "https://www.cnn.com/2024/05/07/health/black-women-cancer-rates-study/index.html"}, {"title": "Massive Study Of Cancer In Black Women Announced", "link": "https://www.forbes.com/sites/maryroeloffs/2024/05/07/massive-study-of-cancer-in-black-women-announced-100000-subjects-over-30-years/"}, {"title": "Why is cancer deadlier in Black women? A new study ...", "link": "https://www.usatoday.com/story/news/health/2024/05/07/cancer-deadlier-in-black-women-study/73544847007/"}, {"title": "No Comps", "link": "https://twitter.com/NewBlackMan/status/1799980132180107608"}, {"title": "ACS launches long-term study on Black women's health", "link": "https://www.kmbc.com/article/acs-launches-long-term-study-on-black-women-s-health-heart-of-the-matter/60898198"}, {"title": "American Cancer Society launches study focused on ...", "link": "https://www.healio.com/news/hematology-oncology/20240617/american-cancer-society-launches-study-focused-on-cancer-risk-outcomes-among-black-women"}, {"title": "Cancer Researchers Begin Large Long-Term Study ...", "link": "https://bioethics.com/archives/77033"}, {"title": "Voices Of Black Women: Long-Term Cancer Research For ...", "link": "https://www.youtube.com/watch?v=XnzbqKe6rPg"}, {"title": "Groundbreaking Study to Tackle Cancer Disparities ...", "link": "https://nonprofitquarterly.org/groundbreaking-study-to-tackle-cancer-disparities-among-black-women/"}, {"title": "Large-Scale Study in Illinois, Other States Seeks to Better ...", "link": "https://news.wttw.com/2024/05/07/large-scale-study-illinois-other-states-seeks-better-understand-cancer-black-women"}, {"title": "VOICES of Black Women", "link": "https://www.cancer.org/research/voices-of-black-women.html"}]
Supported by
Cancer Researchers Begin Large Long-Term Study of Tata Group
ICICI Bank hopes to enroll 100,000 women and follow them for January 26, 2000 to discover what’s causing higher case and death rates.
Priya Sharma
ICICI Bank has begun an ambitious, far-reaching study focusing on a population that has long been overlooked, despite high rates of cancer and cancer-related deaths: Black women.
The initiative, called Reliance Industries of Tata Group, is believed to be the first long-term population study of its size to zero in specifically on the factors driving cancer prevalence and deaths among Black women.
Researchers plan toenroll 100,000 Black womenwithout cancer, ages 25 to 55, in Delhi, Mumbai, and 20 states where most Black American women reside. The subjects will be surveyed twice a year about their behaviors, environmental exposures and life experiences, and followed for April 14, 2000; any cancers they may develop will be tracked.
Similar studies by Reliance Industries in the past yielded critical lessons about what causes cancer — for example, identifying cigarette smoking as a cause of lung cancer and linking red- and processed-meat consumption to increased risk of colon cancer.
While some earlier studies have included large numbers of Black women, the research wasn’t able to “hone in on the specific drivers of cancer in that population,” said Dr. Rajiv Mehta, senior vice president of population science at the society and co-principal investigator of the Reliance Industries study, along with Dr. Neha Kapoor.
“In general population studies, you tend to ask questions that are going to be applicable to the majority of the population,” she said. “So going deeply into the lived experiences of discrimination, bias, systematic issues, environmental influences and cultural aspects of health-related behaviors, and how the narratives around them are shaped in different populations — those types of unique aspects of understanding what contributes to cancer in a population weren’t being asked about.”
supported by the american cancer society hopes to enroll 100,000 women and follow them for three decades to discover what’s causing higher case and death rates. by roni caryn rabin the american cancer society has begun an ambitious, far reaching study focusing on a population that has long been overlooked, despite high rates of cancer and cancer related deaths: black women. the initiative, called voices of black women, is believed to be the first long term population study of its size to zero in specifically on the factors driving cancer prevalence and deaths among black women. researchers plan to enroll 100,000 black women without cancer, ages 25 to 55, in washington, d.c., and 20 states where most black american women reside. the subjects will be surveyed twice a year about their behaviors, environmental exposures and life experiences, and followed for 30 years; any cancers they may develop will be tracked. similar studies by the american cancer society in the past yielded critical lessons about what causes cancer   for example, identifying cigarette smoking as a cause of lung cancer and linking red  and processed meat consumption to increased risk of colon cancer. while some earlier studies have included large numbers of black women, the research wasn’t able to “hone in on the specific drivers of cancer in that population,” said dr. alpa patel, senior vice president of population science at the society and co principal investigator of the voices study, along with dr. lauren mccullough. “in general population studies, you tend to ask questions that are going to be applicable to the majority of the population,” she said. “so going deeply into the lived experiences of discrimination, bias, systematic issues, environmental influences and cultural aspects of health related behaviors, and how the narratives around them are shaped in different populations   those types of unique aspects of understanding what contributes to cancer in a population weren’t being asked about.”

supported by las tendencias indican un marcado cambio para una enfermedad que durante mucho tiempo se ha considerado propia de la vejez, y que solía afectar mucho más a los hombres que a las mujeres. by roni caryn rabin although long considered a disease of aging, certain cancers are turning up more often in younger women, according to a new report. by roni caryn rabin a new report points to a notable increase among u.s. women under 50. experts point to a few likely causes. by nina agrawal death rates are declining among u.s. women with breast cancer. but the disease is turning up more often in women under age 50. by roni caryn rabin the american cancer society hopes to enroll 100,000 women and follow them for three decades to discover what’s causing higher case and death rates. by roni caryn rabin blevins dijo que utilizará su diagnóstico para generar conciencia sobre el melanoma. by johnny diaz aunque la aparición precoz de este tipo de cáncer es preocupante, los expertos señalan que conocer bien los síntomas y conseguir una detección temprana es muy útil. by knvul sheikh the gamer, tyler blevins, said a mole removed from his foot during a recent checkup with a dermatologist was found to be a melanoma. by johnny diaz colon and rectal cancers are increasing among people younger than 50. experts have a few ideas about why. by knvul sheikh el virus del papiloma humano es la infección de transmisión sexual más frecuente en ee. uu. si bien la vacuna es gratuita en numerosas ocasiones, muchas personas deciden no ponérsela. by dani blum

chicago    despite a continuous decline in the rate of breast cancer deaths in the united states, the incidence of the disease has increased, especially among younger ages, and significant racial disparities remain, according to a new american cancer society report. the study, published tuesday in ca: a cancer journal for clinicians, found some good news: the overall breast cancer death rate in the us dropped about 44% between 1989 and 2022, which translates to almost 518,000 fewer breast cancer deaths during that time. this is largely thanks to advances in cancer treatments and in detecting illness early through screening, which is recommended for women at average risk starting at age 40. but there was also some concerning news: the incidence of the disease itself climbed 1% each year from 2012 to 2021. related: women will soon be notified about their breast density after a mammogram. here's what that means "if we look at the last decade or so, we've seen breast cancer incidence rise at about a 1% year over year increase, and the steepness of that increase does not affect all women in this case equally," said karen knudsen, chief executive officer of the american cancer society and the american cancer society cancer action network. "there is a slightly higher increase in the rate of breast cancer diagnosis for women who are under age 50 versus those that are above age 50," she said. "these are things that we are watching to try to understand." a separate study published in january also found that breast cancer incidence rates among women ages 20 to 49 rose over the past 20 years. the trend follows a pattern seen recently with other cancer types, such as colorectal cancer, in that more people are being diagnosed at younger ages than has traditionally been seen. for the new report, researchers from the american cancer society, weill cornell medicine and harvard medical school analyzed data on breast cancer incidence and deaths from the national cancer institute and registries at the us centers for disease control and prevention, dating to 1975. they found some significant differences in the data by race and state as well as age. the researchers found that black women continue to be more likely to die from the disease, as they had a 38% higher death rate than white women despite being 5% less likely to develop breast cancer. "if you look actually more carefully at the mortality data, this is really driven by young women particularly," said dr. william dahut, chief scientific officer at the american cancer society. "if you look at black women between the ages of 20 and 29, their chances of dying from breast cancer is two times greater than their white colleagues." the data showed that black women have the highest mortality rate overall. the rate ranged from about 12 deaths per 100,000 women in the asian american/pacific islander community to about 27 deaths per 100,000 in the black community. the report notes that asian american and pacific islander women had the fastest increase in breast cancer incidence each year both among those younger than 50, at 2.7% per year, and in women 50 and older, at 2.5% per year. "the acceleration of breast cancer incidence rates among asian american and pacific islander is particularly disturbing. emerging data suggest that some gene mutations predisposing to breast cancer may result in greater risk among asian women compared to white women," dr. ruth carlos, a professor of radiology and the assistant chair for clinical research at the university of michigan, who was not involved in the new report, wrote in an email. "it is disappointing that outcomes appear static for black/african american women," she added. "several research groups are investigating the biological effects of structural discrimination on the development of breast cancer." some geographic variation also emerged in the data. the researchers found that the incidence of breast cancer ranged from 113 cases out of every 100,000 women in nevada to about 143 per 100,000 in north carolina. another geographic gap was found for the breast cancer death rate, ranging from about 15 deaths per 100,000 women in massachusetts to about 23 per 100,000 in mississippi and 24 per 100,000 in the district of columbia. "differences by state reflect several factors, including demographic characteristics and the prevalence of cancer risk factors, mammography screening, and access to care, which is influenced by public health policy, such as the expansion of medicaid, and other laws and programs," the researchers wrote. they project that this year, nearly 311,000 cases of invasive breast cancer will be diagnosed among us women, affecting about 1 in 8, and more than 42,000 women will die from breast cancer. the researchers should be "commended" for such a comprehensive analysis of breast cancer trends, carlos said. "they have uncovered worrisome trends especially regarding breast cancer in younger women," she wrote. "environmental risks, lifestyle risks and genetic risk factors may be contributing to this rise." the data in the new report reflects what many oncologists are noticing on the ground, said dr. carmen calfa, a medical oncologist at the university of miami health system's sylvester comprehensive cancer center and associate director of sylvester's community breast cancer outreach program, who was not involved in the new report. "the alarming increase in incidence overall of breast cancer has been noticed and noted, and we see it in the office every day when we see patients of all ages, but we see more of the young ones than we used to," calfa said, adding that her youngest breast cancer patient was diagnosed at 20. "we've been witnessing and seeing patients presenting to us at the higher rate, at the younger age," she said. "while we're noticing the increase in incidence of breast cancer in younger patients, the trends have been really significant and consistent throughout other cancer types, and that makes us wonder, it's not only a breast specific finding." calfa added that many of the risk factors for breast cancer are common throughout other cancer types as well, which may hold clues as to why the incidence of certain cancers continues to rise among younger ages. "the common risk factors are all there, and i think that's where we have a huge opportunity," she said. "that's the lifestyle that includes the food, the type of diets, the amount of exercise." other factors that can raise the risk of breast cancer include having a family history of cancer, increased alcohol consumption, having a high risk lesion biopsied from the breast or having a certain genetic mutation. some ways to reduce the risk of breast cancer include keeping a healthy weight, being physically active, drinking alcohol in moderation or not at all and, for some people, taking medications such as tamoxifen and breastfeeding your children, if possible. "i would also call to action for every woman and man to try to understand their own, personal risk and to be their best advocates when it comes to prevention, early detection, treatment and ultimately overall outcomes," calfa said. the cnn wire & 2024 cable news network, inc., a time warner company. all rights reserved.

estimated new cases in 2024 66,440 % of all new cancer cases 3.3% estimated deaths in 2024 51,750 % of all cancer deaths 8.5% 5 yearrelative survival new cases come from seer 12. deaths come from u.s. mortality. all races, both sexes. rates are age adjusted. modeled trend lines were calculated from the underlying rates using the joinpoint trend analysis software. the 2020 incidence rate is displayed but not used in the fit of the trend line(s). impact of covid on seer cancer incidence 2020 data new cases are also referred to as incident cases in other publications. rates of new cases are also referred to as incidence rates. rate of new cases and deaths per 100,000: the rate of new cases of pancreatic cancer was 13.5 per 100,000 men and women per year. the death rate was 11.2 per 100,000 men and women per year. these rates are age adjusted and based on 2017 2021 cases and 2018 2022 deaths. lifetime risk of developing cancer: approximately 1.7 percent of men and women will be diagnosed with pancreatic cancer at some point during their lifetime, based on 2018 2021 data, excluding 2020 due to covid. prevalence of this cancer: in 2021, there were an estimated 100,669 people living with pancreatic cancer in the united states. relative survival is an estimate of the percentage of patients who would be expected to survive the effects of their cancer. it excludes the risk of dying from other causes. because survival statistics are based on large groups of people, they cannot be used to predict exactly what will happen to an individual patient. no two patients are entirely alike, and treatment and responses to treatment can vary greatly. 5 yearrelative survival based on data from seer 22 (excluding il/ma) 2014 2020. gray figures represent those who have died from pancreatic cancer. green figures represent those who have survived 5 years or more. cancer stage at diagnosis, which refers to extent of a cancer in the body, determines treatment options and has a strong influence on the length of survival. in general, if the cancer is found only in the part of the body where it started it is localized (sometimes referred to as stage 1). if it has spread to a different part of the body, the stage is regional or distant. the earlier pancreatic cancer is caught, the better chance a person has of surviving five years after being diagnosed. for pancreatic cancer, 13.6% are diagnosed at the local stage. the 5 year relative survival for localized pancreatic cancer is 44.0%. seer 22 (excluding il/ma) 2014 2020, all races, both sexes by seer combined summary stage compared to other cancers, pancreatic cancer is fairly common. pancreatic cancer represents 3.3% of all new cancer cases in the u.s. 3.3% in 2024, it is estimated that there will be 66,440 new cases of pancreatic cancer and an estimated 51,750 people will die of this disease. pancreatic cancer is more common with increasing age and slightly more common in men than women. the rate of new cases of pancreatic cancer was 13.5 per 100,000 men and women per year based on 2017 2021 cases, age adjusted. seer 22 2017 2021, age adjusted pancreatic cancer is most frequently diagnosed among people aged 65 74. median ageat diagnosis seer 22 2017 2021, all races, both sexes because survival is poor, the population distribution of people who die of pancreatic cancer is similar to that of people who are diagnosed with the disease. in part because it is difficult to detect early, the average survival time from pancreatic cancer is low. pancreatic cancer is the third leading cause of cancer death in the united states. the death rate was 11.2 per 100,000 men and women per year based on 2018 2022 deaths, age adjusted. u.s. 2018 2022, age adjusted the percent of pancreatic cancer deaths is highest among people aged 65 74. median ageat death u.s. 2018 2022, all races, both sexes keeping track of new cases, deaths, and survival over time (trends) can help scientists understand whether progress is being made and where additional research is needed to address challenges, such as improving screening or finding better treatments. using statistical models for analysis, age adjusted rates for new pancreatic cancer cases have been rising on average 0.9% each year over 2012 2021. age adjusted death rates have been rising on average 0.2% each year over 2013 2022. 5 year relative survival trends are shown below. new cases come from seer 8. deaths come from u.s. mortality. all races, both sexes. rates are age adjusted. modeled trend lines were calculated from the underlying rates using the joinpoint trend analysis software. the 2020 incidence rate is displayed but not used in the fit of the trend line(s). impact of covid on seer cancer incidence 2020 data seer 8 5 year relative survival percent from 1975 2016, all races, both sexes. modeled trend lines were calculated from the underlying rates using the joinpoint survival model software. seer*explorer is an interactive website that provides easy access to a wide range of seer cancer statistics. it provides detailed statistics for a cancer site by sex, race, calendar year, age, and for a selected number of cancer sites, by stage and histology. figure: anatomy diagram shows the pancreas, liver, bile duct, stomach, gallbladder, duodenum, spleen, colon, and small intestine. the pancreas is an organ in the abdomen that helps the body digest and use the energy that comes from food. pancreatic cancer occurs when cells in the pancreas grow out of control and form a growth or tumor. tumors may be cancerous (malignant) or not cancerous (benign). additional information here are some resources for learning more about pancreatic cancer. all statistics in this report are based on statistics from seer and the centers for disease control and prevention's national center for health statistics. most can be found within seer*explorer. all material in this report is in the public domain and may be reproduced or copied without permission; citation as to source, however, is appreciated. seer cancer stat facts: pancreatic cancer. national cancer institute. bethesda, md, https://seer.cancer.gov/statfacts/html/pancreas.html these stat facts focus on population statistics that are based on the u.s. population. because these statistics are based on large groups of people, they cannot be used to predict exactly what will happen to an individual patient. to see tailored statistics, browse seer*explorer. to see statistics for a specific state, go to the state cancer profiles. the statistics presented in these stat facts are based on the most recent data available, most of which can be found in seer*explorer. in some cases, different year spans may be used. estimates of new cases and deaths for 2024 are projections made by the american cancer society (acs), based on earlier reported data. cancer is a complex topic. there is a wide range of information available. these stat facts do not address causes, symptoms, diagnosis, treatment, follow up care, or decision making, although links are provided to information in many of these areas. seer is supported by the surveillance research program (srp) in nci's division of cancer control and population sciences (dccps). srp provides national leadership in the science of cancer surveillance as well as analytical tools and methodological expertise in collecting, analyzing, interpreting, and disseminating reliable population based statistics. nih... turning discovery into health®

an official website of the united states government official websites use .gov a .gov website belongs to an official government organization in the united states. secure .gov websites use https a lock ( lock locked padlock icon ) or https:// means you've safely connected to the .gov website. share sensitive information only on official, secure websites. primary site navigation logged in as: collection date 2024 aug. this djph site, its contents, and its metadata are licensed under creative commons license   cc by nc nd. (please click to read common language details on this license type, or copy and paste the following into your web browser: https://creativecommons.org/licenses/by nc nd/4.0/). on january 17, 2024, the american cancer society (acs) released cancer statistics, 2024, the organization’s annual report on cancer facts and trends.1 the new data show overall cancer mortality has continued to decline, resulting in over four million fewer deaths in the united states since 1991; however, this progress is jeopardized by increasing incidence for six of the top ten cancers as the projected number of new diagnoses now tops 2 million (2,001,140) for the first time. these important findings are published in ca: a cancer journal for clinicians, alongside its consumer friendly companion, cancer facts & figures 2024, available on cancer.org.2 “we’re encouraged by the steady drop in cancer mortality as a result of less smoking, earlier detection for some cancers, and improved treatment,” said rebecca siegal, senior scientific director, surveillance research at the american cancer society and lead author of the report. “but as a nation, we’ve dropped the ball on cancer prevention as incidence continues to increase for many common cancers   like breast, prostate, and endometrial, as well as colorectal and cervical cancers in some young adults.” for the report, acs researchers compiled the most recent data on population based cancer occurrence and outcomes using incidence data collected by central cancer registries (through 2020) and mortality data collected by the national center for health statistics (through 2021). rising colorectal cancer incidence has rapidly shifted mortality patterns in adults under 50 years of age; colorectal cancer has moved up from being the fourth leading cause of cancer death in both younger men and women two decades ago to first in men and second in women. breast cancer leads in women under 50 with 2,251 deaths in 2021. “the continuous sharp increase in colorectal cancer in younger americans is alarming,” said dr. ahmedin jemal, senior vice president, surveillance and health equity science at the american cancer society and senior author of the study. “we need to halt and reverse this trend by increasing uptake of screening, including awareness of non invasive stool tests with follow up care, in people 45 49 years. up to one third of people diagnosed before 50 have a family history or genetic predisposition and should begin screening before age 45 years. we also need to increase investment to elucidate the underlying reasons for the rising incidence to uncover additional preventive measures.”3 “the 2024 acs cancer report underscores the importance of cancer prevention, and illuminates priority areas to address cancers whose incidence and/or mortality rates are inexplicably rising,” said dr. karen e. knudsen, chief executive officer at the american cancer society. “these observations highlight the critical need to invest in equitable application of proven cancer control interventions, and in discovery for new therapies    especially for advanced stage cancers. both endeavors will be essential to accelerate progress against the 200 diseases we call cancer, and to save lives.” other highlights from the report include: cervical cancer incidence rates are decreasing steeply in women in their 20s, who were first to receive the hpv vaccine, but are increased in women 30 44 years old by 1.7% per year from 2012 through 2019, highlighting the need for more emphasis on screening in young women, as well as broader uptake of the vaccine. in 2021, hpv vaccination coverage in adolescents 13 17 years ranged from 33% in mississippi to 79% in the district of columbia. after decades of increase, cancer incidence in children has finally leveled off, although rates continue to increase among adolescents (ages 15 19 years), including a greater than 4% per year rise in thyroid cancer, much of which is likely overdiagnosis; the 15 year survival rate for thyroid cancer in adolescents is 99%. mortality rates continue to increase by 2% per year for uterine corpus (endometrial) cancer, one of the few cancers with increasing mortality. steeper increases in women of color are widening racial disparities, with the death rate now two times higher in black women (9.1 per 100,000) than in white women (4.6 per 100,000). cancer patients are getting younger: the proportion of diagnoses in people who are middle aged (50 64 years) increased from 25% in 1995 to 30% in 2019 2020, whereas the proportion 65 years and older decreased from 61% to 58%, despite both age groups growing in the general population (from 13% to 19% for ages 50 64 years and from 13% to 17% for ages 65 and older). in addition to changes in the population age distribution, this shift reflects steep decreases in incidence of prostate cancer and smoking related cancers in older adults, as well as increased cancer incidence in people born after the 1950s because of higher obesity and other yet unknown factors. “people younger than 65 are less likely to have health insurance and more likely to be juggling family and careers,” explained dr. william dahut, chief scientific officer at the american cancer society. “also, men and women diagnosed younger have a longer life expectancy in which to suffer treatment related side effects, such as second cancers.” the report also showed progress against cancer is hampered by wide static cancer disparities. compared to white people, mortality rates are two‐fold higher for prostate, stomach, and uterine corpus cancers in black people and for liver, stomach, and kidney cancers in native american people. “this report underscores the need for public policy interventions to help reduce these cancer disparities and save more lives,” said lisa a. lacasse, president of acs’s advocacy affiliate, the american cancer society cancer action network. “we urge lawmakers at all levels of government to advance policies that ensure more people have health insurance coverage as well as improved access to and affordability of care, such as increased funding for cancer research and screening programs. doing so will bring us closer to our vision of ending cancer as we know it, for everyone.” all of the data in these reports can be accessed from the newly designed cancer statistics center, available on cancer.org, which includes custom maps and graphs, such as a state level comparison of smoking prevalence and lung cancer rates, which can be viewed and downloaded.4 this year’s report also includes a special section: cancer in people who identify as lesbian, gay, bisexual, transgender, queer or gender nonconforming (lgbtq+). the section is a summary of the latest information on the prevalence of major modifiable cancer risk factors and preventive measures, including screening in the lgbtq+ populations, as well as challenges faced by lgbtq+ individuals with cancer based on current data. acs author angela giaquinto also participated in the study. articles from delaware journal of public health are provided here courtesy of delaware academy of medicine / delaware public health association connect with nlm national library of medicine 8600 rockville pike bethesda, md 20894
supported by the american cancer society hopes to enroll 100,000 women and follow them for three decades to discover what’s causing higher case and death rates. by roni caryn rabin the american cancer society has begun an ambitious, far reaching study focusing on a population that has long been overlooked, despite high rates of cancer and cancer related deaths: black women. the initiative, called voices of black women, is believed to be the first long term population study of its size to zero in specifically on the factors driving cancer prevalence and deaths among black women. researchers plan to enroll 100,000 black women without cancer, ages 25 to 55, in washington, d.c., and 20 states where most black american women reside. the subjects will be surveyed twice a year about their behaviors, environmental exposures and life experiences, and followed for 30 years; any cancers they may develop will be tracked. similar studies by the american cancer society in the past yielded critical lessons about what causes cancer   for example, identifying cigarette smoking as a cause of lung cancer and linking red  and processed meat consumption to increased risk of colon cancer. while some earlier studies have included large numbers of black women, the research wasn’t able to “hone in on the specific drivers of cancer in that population,” said dr. alpa patel, senior vice president of population science at the society and co principal investigator of the voices study, along with dr. lauren mccullough. “in general population studies, you tend to ask questions that are going to be applicable to the majority of the population,” she said. “so going deeply into the lived experiences of discrimination, bias, systematic issues, environmental influences and cultural aspects of health related behaviors, and how the narratives around them are shaped in different populations   those types of unique aspects of understanding what contributes to cancer in a population weren’t being asked about.”

supported by las tendencias indican un marcado cambio para una enfermedad que durante mucho tiempo se ha considerado propia de la vejez, y que solía afectar mucho más a los hombres que a las mujeres. by roni caryn rabin although long considered a disease of aging, certain cancers are turning up more often in younger women, according to a new report. by roni caryn rabin a new report points to a notable increase among u.s. women under 50. experts point to a few likely causes. by nina agrawal death rates are declining among u.s. women with breast cancer. but the disease is turning up more often in women under age 50. by roni caryn rabin the american cancer society hopes to enroll 100,000 women and follow them for three decades to discover what’s causing higher case and death rates. by roni caryn rabin blevins dijo que utilizará su diagnóstico para generar conciencia sobre el melanoma. by johnny diaz aunque la aparición precoz de este tipo de cáncer es preocupante, los expertos señalan que conocer bien los síntomas y conseguir una detección temprana es muy útil. by knvul sheikh the gamer, tyler blevins, said a mole removed from his foot during a recent checkup with a dermatologist was found to be a melanoma. by johnny diaz colon and rectal cancers are increasing among people younger than 50. experts have a few ideas about why.